Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nakanishi's Other Stockholders Equity for the quarter that ended in Dec. 2025 was 円15,520 Mil.
Nakanishi's quarterly Other Stockholders Equity
increased
from Jun. 2025 (円9,993 Mil) to Sep. 2025 (円12,157 Mil) and
increased
from Sep. 2025 (円12,157 Mil) to Dec. 2025 (円15,520 Mil).
Nakanishi's annual Other Stockholders Equity
increased
from Dec. 2023 (円7,426 Mil) to Dec. 2024 (円13,170 Mil) and
increased
from Dec. 2024 (円13,170 Mil) to Dec. 2025 (円15,520 Mil).
Nakanishi Other Stockholders Equity Related Terms
Nakanishi Other Stockholders Equity Historical Data
* Premium members only.
The historical data trend for Nakanishi's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Stockholders Equity of 円15,520 Mil mean?
Nakanishi (TSE:7716) has a Other Stockholders Equity of 円15,520 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nakanishi and its competitors.
Is Nakanishi's Other Stockholders Equity too high?
Nakanishi's current Other Stockholders Equity is 円15,520 Mil. Overall, Nakanishi has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nakanishi's Other Stockholders Equity compare to ISRG and BDX?
Nakanishi's Other Stockholders Equity of 円15,520 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nakanishi and its competitors. Nakanishi's current Other Stockholders Equity is 円15,520 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakanishi stock overvalued right now?
Based on GuruFocus' analysis, Nakanishi (TSE:7716) is currently considered Fairly Valued. The stock's GF Value™ is 円3,299.61, compared to a current price of 円3,075.00 — trading 6.8% below its estimated fair value. The current Other Stockholders Equity is 円15,520 Mil. Nakanishi's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Nakanishi (TSE:7716), the current Other Stockholders Equity is 円15,520 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nakanishi (TSE:7716) Overvalued in 2026?
Based on GuruFocus' analysis, Nakanishi stock appears to be undervalued.
The current stock price of 円3,075.00 is trading 6.8% below its estimated GF Value™ of 円3,299.61.
GuruFocus considers Nakanishi to be Fairly Valued.
Key valuation signals for TSE:7716:
Other Stockholders Equity: 円15,520 Mil
GF Value™: 円3,299.61 vs. price of 円3,075.00 (6.8% below fair value)
No single metric tells the full story. See the TSE:7716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning its key revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The surgical business segment manufactures and sells grinders for manual works and spindles for machinery attachment. The Machinery business segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
93GF Score
Get the complete analysis for TSE:7716
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7716 has been successfully added to your 
